TANG CAPITAL PARTNERS LP 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 3,440,345 9.960% | 243,899 (+7.63%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 3,196,446 9.400% | 1,796,446 (+128.32%) | Filing |
| 2022-05-26 4:00 pm Purchase | 2022-05-16 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 1,400,000 5.700% | 1,400,000 (New Position) | Filing |